| Literature DB >> 18089867 |
Murielle E L Mauer1, Martin J B Taphoorn, Andrew Bottomley, Corneel Coens, Fabio Efficace, Marc Sanson, Alba A Brandes, Carin C D van der Rijt, Hans J J A Bernsen, Marc Frénay, Cees C Tijssen, Denis Lacombe, Martin J van den Bent.
Abstract
PURPOSE: This is one of a few studies that have explored the value of baseline symptoms and health-related quality of life (HRQOL) in predicting survival in patients with brain cancer. PATIENTS AND METHODS: Baseline HRQOL scores (from the European Organisation for Research and Treatment of Cancer [EORTC] Quality of Life Questionnaire C30 and the EORTC Brain Cancer Module) were examined in 247 patients with anaplastic oligodendrogliomas to determine the relationship with overall survival by using Cox proportional hazards regression models. Refined techniques as the bootstrap resampling procedure and the computation of C indexes and R2 coefficients were used to explore the stability of the models as well as better assess the potential benefit of using HRQOL to predict survival in clinical practice and research.Entities:
Mesh:
Year: 2007 PMID: 18089867 DOI: 10.1200/JCO.2007.11.1476
Source DB: PubMed Journal: J Clin Oncol ISSN: 0732-183X Impact factor: 44.544